Why is GKB Ophthalmics falling/rising?

As of 24-Sep, GKB Ophthalmics Ltd is currently priced at 70.10, reflecting an increase of 0.3 or 0.43%. The stock has been gaining for the last two days, with a total return of 0.85% during this period. However, it is trading below all its moving averages, indicating a bearish trend. Additionally, the stock has underperformed its sector by 0.26% today, and there has been a significant drop in investor participation, with delivery volume falling by 56.55% compared to the 5-day average. The company has shown weak long-term fundamental strength, highlighted by a -166.65% CAGR growth in operating profits over the last five years and a negative EBIT to interest ratio of -0.20, which raises concerns about its ability to service debt.
In the broader market context, GKB Ophthalmics has underperformed the benchmark, with a 1-week return of +0.04% compared to the Sensex's -1.18%. Over the past year, the stock has generated a return of -35.33%, significantly lagging behind the benchmark's -3.77%. This consistent underperformance over the last three years, alongside negative EBITDA and declining profitability, suggests that the stock is viewed as risky by investors. Overall, while there has been a slight uptick in price recently, the underlying fundamentals and market conditions indicate a challenging environment for GKB Ophthalmics.